Toggle navigation
Home
Search
Services
Blog
Contact
About
Recombinant Human C1 Inhibitor for Treatment of Heredit*
Nuijens, Jan H.
Pharming Technologies, B.V., Leiden, Netherlands
Search grants from Jan Nuijens
Search grants from Pharming Technologies, B.V.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dynamics of airway microbiota at pulmonary exacerbation in cystic fibrosis
Pathogenesis of Sleep Disordered Breathing in Spinal Cord Injury Patients
Increase Rab11 Activity as HD Therapy
Super-resolution Reconstruction of Fetal Craniofacial MRI
Adaptation in the Drosophila innate immune response
Recently added grants:
Coregistered Photoacoustic and Ultrasound Imaging for Ovarian Cancer Diagnosis and Risk Management
Enhancing Breast Tumor Cell Immunogenicity by Targeting the Epigenetic Factor NURF
Imaging neuromodulation in the brain
Membrane Trafficking of Opioid and Adrenergic Receptors
Comparative Pharmacology of Cannabinoids in Rodent Models
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
3R01FD003086-01S1
Application #
7675911
Study Section
Special Emphasis Panel (ZFD1-OPD-L (C1))
Program Officer
Ganti, Usha
Project Start
2006-09-20
Project End
2009-08-31
Budget Start
2006-09-20
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
Indirect Cost
Institution
Name
Pharming Technologies, B.V.
Department
Type
DUNS #
City
Leiden
State
Country
Netherlands
Zip Code
Related projects
NIH 2008
R01 FD
Recombinant Human C1 Inhibitor for Treatment of Heredit*
Nuijens, Jan H. / Pharming Technologies, B.V.
NIH 2006
R01 FD
Recombinant Human C1 Inhibitor for Treatment of Heredit*
Nuijens, Jan H. / Pharming Technologies, B.V.
Comments
Be the first to comment on Jan Nuijens's grant
